Our results suggest that AKR1C3 promotes intracellular lipid storage and inhibits fatty acid oxidation, thus protecting HCC cells from acylcarnitine-induced mitochondrial dysfunction. Here, AKR1C3 is linked to hepatocellular carcinoma.